Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.
作者信息
Morgan Scott C, Hoffman Karen, Loblaw D Andrew, Buyyounouski Mark K, Patton Caroline, Barocas Daniel, Bentzen Soren, Chang Michael, Efstathiou Jason, Greany Patrick, Halvorsen Per, Koontz Bridget F, Lawton Colleen, Leyrer C Marc, Lin Daniel, Ray Michael, Sandler Howard
机构信息
Scott C. Morgan, The Ottawa Hospital and University of Ottawa, Ottawa; D. Andrew Loblaw, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Karen Hoffman, MD Anderson Cancer Center, Houston, TX; Mark K. Buyyounouski, Stanford University, Stanford; Palto Alto VA Health System, Palo Alto, CA; Caroline Patton, American Society for Radiation Oncology, Arlington, VA; Daniel Barocas, Vanderbilt University Medical Center, Nashville, TN; Soren Bentzen, University of Maryland School of Medicine, Baltimore, MD; Michael Chang, Hunter Holmes McGuire VA Medical Center and Virginia Commonwealth University, Richmond, VA; Jason Efstathiou, Massachusetts General Hospital, Boston MA; Patrick Greany, Patient representative, Tallahassee, FL; Per Halvorsen, Lahey Hospital and Medical Center, Burlington, MA; Bridget F. Koontz, Duke University Medical Center, Durham, NC; Colleen Lawton, Medical College of Wisconsin, Milwaukee, WI; C. Marc Leyrer, Wake Forest University, Winston-Salem, NC; Daniel Lin, University of Washington, Seattle, WA; Michael Ray, Radiology Associates of Appleton, ThedaCare Regional Cancer Center, Appleton, WI; and Howard Sandler, Cedars-Sinai Medical Center, Los Angeles, CA.
出版信息
J Clin Oncol. 2018 Oct 11;36(34):JCO1801097. doi: 10.1200/JCO.18.01097.
Abstract
摘要
相似文献
1
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.局部前列腺癌的大分割放射治疗：美国放射肿瘤学会、美国临床肿瘤学会和美国泌尿外科学会循证指南
J Clin Oncol. 2018 Oct 11;36(34):JCO1801097. doi: 10.1200/JCO.18.01097.
2
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.局限性前列腺癌的分割放疗：ASTRO、ASCO 和 AUA 循证指南的执行摘要。
Pract Radiat Oncol. 2018 Nov-Dec;8(6):354-360. doi: 10.1016/j.prro.2018.08.002. Epub 2018 Oct 11.
3
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline.局限性前列腺癌的分割放疗：ASTRO、ASCO 和 AUA 循证指南的执行摘要。
J Urol. 2019 Mar;201(3):528-534. doi: 10.1097/JU.0000000000000071.
4
Important Technical Considerations for Implementing the ASTRO/ASCO/AUA Prostate Cancer Hypofractionated Radiation Guideline.实施美国放射肿瘤学会（ASTRO）/美国临床肿瘤学会（ASCO）/美国泌尿外科学会（AUA）前列腺癌大分割放疗指南的重要技术考量
Pract Radiat Oncol. 2019 Jul-Aug;9(4):197-199. doi: 10.1016/j.prro.2019.02.017. Epub 2019 Mar 2.
5
Radiation Therapy Summary of the AUA/ASTRO Guideline on Clinically Localized Prostate Cancer.AUA/ASTRO 临床局限性前列腺癌治疗指南概要
Pract Radiat Oncol. 2024 Jan-Feb;14(1):47-56. doi: 10.1016/j.prro.2023.09.007.
6
Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.脑胶质瘤放射治疗：美国临床肿瘤学会临床实践指南对美国放射肿瘤学会指南的认可。
J Clin Oncol. 2017 Jan 20;35(3):361-369. doi: 10.1200/JCO.2016.70.7562. Epub 2016 Nov 28.
7
Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.头颈部鳞状细胞癌的放射治疗：美国临床肿瘤学会对美国放射肿瘤学会循证临床实践指南的认可。
J Clin Oncol. 2017 Dec 20;35(36):4078-4090. doi: 10.1200/JCO.2017.73.8633. Epub 2017 Oct 24.
8
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions.临床局限性前列腺癌：AUA/ASTRO 指南。第三部分：放射治疗原则和未来方向。
J Urol. 2022 Jul;208(1):26-33. doi: 10.1097/JU.0000000000002759. Epub 2022 May 10.
9
Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an AUA/ASTRO/SUO Guideline Summary.临床局限性前列腺癌：美国临床肿瘤学会（ASCO）对美国泌尿外科学会（AUA）/美国放射肿瘤学会（ASTRO）/美国泌尿外科护士协会（SUO）指南摘要的临床实践指南认可。
J Oncol Pract. 2018 Oct;14(10):618-624. doi: 10.1200/JOP.18.00434. Epub 2018 Sep 10.
10
Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline.小细胞肺癌的放射治疗：ASCO 指南对 ASTRO 指南的认可。
J Clin Oncol. 2021 Mar 10;39(8):931-939. doi: 10.1200/JCO.20.03364. Epub 2021 Jan 27.
引用本文的文献
1
Moderately hypofractionated online adaptive radiotherapy (SWIFT-1) in cervical cancer patients: study protocol for a multi-centered, open-label, two-arm, phase III, randomized controlled study.宫颈癌患者的中度超分割在线自适应放疗（SWIFT-1）：一项多中心、开放标签、双臂、III期随机对照研究的研究方案
Radiat Oncol. 2025 Jul 16;20(1):112. doi: 10.1186/s13014-025-02688-7.
2
Tomotherapy With Synchrony Fiducial Tracking for Stereotactic Body Radiotherapy in Prostate Cancer: A Single-Center Experience on Toxicity.采用同步基准跟踪的螺旋断层放射治疗用于前列腺癌立体定向体部放射治疗：单中心毒性经验
Cureus. 2025 May 30;17(5):e85083. doi: 10.7759/cureus.85083. eCollection 2025 May.
3
Narrative review of focal boost to intraprostatic dominant lesion in intensity-modulated radiation therapy for localized or locally advanced prostate cancer.关于局部或局部晚期前列腺癌调强放射治疗中前列腺内主要病灶局部增敏的叙述性综述。
Int J Clin Oncol. 2025 Jun 8. doi: 10.1007/s10147-025-02799-x.
4
Single-Dose Radiation Therapy for Localized Prostate Cancer: Where Does the Evidence Lead?局限性前列腺癌的单剂量放射治疗：证据指向何方？
Cancers (Basel). 2025 Mar 31;17(7):1176. doi: 10.3390/cancers17071176.
5
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study.老年（≥75岁）局限性前列腺癌患者的大分割放疗：来自IPOPROMISE研究的多中心回顾性分析
Prostate Cancer Prostatic Dis. 2025 Mar 17. doi: 10.1038/s41391-025-00962-z.
6
A Phase I/II Study of Ultra-Hypofractionated Carbon-ion Radiation therapy for Low- and Intermediate-Risk Localized Prostate Cancer.低危和中危局限性前列腺癌超分割碳离子放射治疗的I/II期研究
Adv Radiat Oncol. 2025 Jan 11;10(3):101705. doi: 10.1016/j.adro.2024.101705. eCollection 2025 Mar.
7
Moderate Hypofractionated Post-Prostatectomy Radiotherapy (MYSTERY) Versus Conventionally Fractionated Post-Prostatectomy Radiotherapy (COPORT) for the Patients With Localized Prostate Cancer: The Protocol of a Prospective, Randomized Trial.中度低分割前列腺切除术后放疗（MYSTERY）与传统分割前列腺切除术后放疗（COPORT）治疗局限性前列腺癌患者的前瞻性随机试验方案
Cancer Control. 2025 Jan-Dec;32:10732748251317682. doi: 10.1177/10732748251317682.
8
Highly hypofractionated biaxially rotational dynamic radiation therapy (BROAD-RT) for high-risk prostate cancer.高分割双轴旋转动态放射治疗（BROAD-RT）用于高危前列腺癌。
Cancer Sci. 2025 Apr;116(4):1004-1011. doi: 10.1111/cas.16429. Epub 2025 Jan 20.
9
The status quo of global geriatric radiation oncology education: A scoping review.全球老年放射肿瘤学教育现状：一项范围综述。
Tech Innov Patient Support Radiat Oncol. 2024 Nov 10;32:100288. doi: 10.1016/j.tipsro.2024.100288. eCollection 2024 Dec.
10
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 3. Genitourinary and gynecological cancers.大分割放疗的循证临床建议：疗效与安全性探索 - 第3部分。泌尿生殖系统和妇科癌症。
Radiat Oncol J. 2024 Sep;42(3):171-180. doi: 10.3857/roj.2023.01046. Epub 2024 Jul 8.
本文引用的文献
1
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options.临床局限性前列腺癌：AUA/ASTRO/SUO 指南。第二部分：推荐方法和特定治疗方案的详细信息。
J Urol. 2018 Apr;199(4):990-997. doi: 10.1016/j.juro.2018.01.002. Epub 2018 Jan 10.
2
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.临床局限性前列腺癌：AUA/ASTRO/SUO 指南。第 I 部分：风险分层、共同决策和治疗选择。
J Urol. 2018 Mar;199(3):683-690. doi: 10.1016/j.juro.2017.11.095. Epub 2017 Dec 15.
3
Moderate Hypofractionation in High-Risk, Organ-Confined Prostate Cancer: Final Results of a Phase III Randomized Trial.中高危局限性前列腺癌的适度分割放疗：III 期随机试验的最终结果。
J Clin Oncol. 2017 Jun 10;35(17):1891-1897. doi: 10.1200/JCO.2016.70.4189. Epub 2017 Mar 29.
4
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.随机分组试验：一种低分割辐射方案治疗局限性前列腺癌。
J Clin Oncol. 2017 Jun 10;35(17):1884-1890. doi: 10.1200/JCO.2016.71.7397. Epub 2017 Mar 15.
5
Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer.一项针对局限性前列腺癌的传统放疗与大分割放疗的3期随机前瞻性试验的长期患者报告结局
Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):722-731. doi: 10.1016/j.ijrobp.2016.12.034. Epub 2016 Dec 28.
6
Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial.前列腺放射治疗中直肠分离的持续获益：一项III期试验的最终结果
Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):976-985. doi: 10.1016/j.ijrobp.2016.12.024. Epub 2016 Dec 23.
7
Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer.立体定向体部放疗（SBRT）治疗低中危前列腺癌II期研究的毒性和生活质量报告
Radiat Oncol. 2017 Jan 13;12(1):14. doi: 10.1186/s13014-016-0758-8.
8
Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer.立体定向体部放射治疗（SBRT）治疗前列腺癌后与健康相关的生活质量多领域下降的预测因素。
Cancer. 2017 May 1;123(9):1635-1642. doi: 10.1002/cncr.30519. Epub 2016 Dec 21.
9
Moderate hypofractionated radiotherapy is more effective and safe for localized prostate cancer patients: a meta-analysis.适度低分割放疗对局限性前列腺癌患者更有效且更安全：一项荟萃分析。
Oncotarget. 2017 Jan 10;8(2):2647-2658. doi: 10.18632/oncotarget.13735.
10
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer.立体定向体部放射治疗与中度低分割放疗治疗临床局限性前列腺癌后患者报告的生活质量
Radiother Oncol. 2016 Nov;121(2):294-298. doi: 10.1016/j.radonc.2016.10.013. Epub 2016 Nov 24.
Zotero 插件